Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was applied; no changes to the study details are evident.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous government-funding status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label capitalization and the 'No FEAR Act Data' notices.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.